Lv1
30 积分 2023-11-21 加入
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
4天前
已完结
GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis
7天前
已完结
Nanotherapy for human papillomavirus-associated cancers: breakthroughs and challenges
8天前
已完结
Vaccines for HPV-associated diseases
8天前
已完结
Prevention of Anal Cancer in High-Risk Individuals
18天前
已完结
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
1个月前
已完结
Childhood growth hormone treatment and metabolic and cardiovascular risk in adults born small for gestational age after growth hormone cessation in the Netherlands: a 12-year follow-up study
1个月前
已完结
Auxological and metabolic effects of long-term treatment with recombinant growth hormone in children born small for gestational age: a retrospective study
1个月前
已完结
The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases
1个月前
已完结
Childhood growth hormone treatment: challenges, opportunities, and considerations
1个月前
已完结
皖公网安备34019202002308
